3.265USD+2.19%Mkt Cap: 897.49M USDP/E: —Last update: 2026-06-01
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap897.49M USD
Enterprise Value902.64M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-244.17M USD
Revenue/Share—
Last Price3.265 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.13
PEG—
EV/EBITDA-5.36
EV/Revenue—
P/S—
P/B5.47
EPS (TTM)-0.92
EPS (Forward)-0.54
52W Range
2.10026% of range6.550
52W High6.550 USD
52W Low2.100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-151.77%
ROA-58.57%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-143.83M USD
CapEx (TTM)938.00K USD
FCF Margin—
FCF Yield-3.31%
Net Debt-18.51M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.49
Current Ratio1.29
Quick Ratio1.17
Book Value/Sh0.6030 USD
Cash/Share0.3630 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)8.571 USD
Target Range7.000 USD – 12.00 USD
# Analysts7
Ownership
Shares Out.278.29M
Float169.91M
Insiders6.51%
Institutions82.84%
Short Interest
Short Ratio9.9d
Short % Float24.62%
Short % Out.13.82%
Shares Short38.47M
Short (prev mo.)40.88M
Technical
SMA 503.238 (+0.8%)
SMA 2003.862 (-15.5%)
Beta2.18
S&P 52W Chg27.70%
Avg Vol (30d)3.65M
Avg Vol (10d)5.58M
Technical Indicators
RSI (14)48.2
MACD-0.0689
MACD Signal-0.0652
MACD Hist.-0.0037
BB Upper3.643 USD
BB Middle3.247 USD
BB Lower2.852 USD
BB Width24.35%
ATR (14)0.2120 USD
Vol Ratio (20d)0.71x